<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03382353</url>
  </required_header>
  <id_info>
    <org_study_id>GR-2011-02350494</org_study_id>
    <nct_id>NCT03382353</nct_id>
  </id_info>
  <brief_title>EMuNI Project: Multiple Nonpharmacological Interventions</brief_title>
  <acronym>EMuNI</acronym>
  <official_title>Efficacy of Multiple Nonpharmacological Interventions in Individuals With Subjective Memory Complaints</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Centro San Giovanni di Dio Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ospedale San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituto Di Ricerche Farmacologiche Mario Negri</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Centro San Giovanni di Dio Fatebenefratelli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      By 2030, the global prevalence of Alzheimer's Disease (AD) is predicted to reach 65.7 million
      worldwide. Despite extensive research efforts, a cure for AD has not been identified. Recent
      studies on non-demented individuals have demonstrated the importance of a healthy lifestyle
      (physical exercise, healthy diet) and non pharmacological interventions (diet supplements) to
      delay the onset of the cognitive decline (Vemuri P et al., 2012). Given that AD is a
      multi-factorial disorder, some multi- component interventions at early stages could be the
      best strategy currently available to delay the AD onset. The aim of this study is to
      investigate the effects of combined non-pharmacological interventions, at different levels of
      intensity, on cognitive performance, on basic (hippocampal, brain ventricle volumes and white
      matter lesions) and advanced magnetic resonance imaging (MRI) markers (Resting-state
      Functional MRI, Probabilistic Diffusion Tensor Tractography
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND Recent evidence showed that aerobic exercise, dietary habits and nutritional
      supplements consumption seem essential for maintaining good cognitive performances increasing
      hippocampal volume (HV) in healthy elderly people (Erickson et al., 2011; Bowman et al.,
      2012). Computerized cognitive trainings are effective in improving cognitive functions of
      healthy older adults (Lampit et al., 2014). Subjective memory complaint (SMC) individuals
      showed HV, white matter lesions (WML) and brain ventricle volumes (BVV) at limits of
      normative population (Cavedo et al., 2012) supporting the hypothesis that they are persons at
      risk of AD (Sperling et al., 2011). The above non-pharmacological treatments, when separately
      applied, do not impact on cognition and neuropathological processes of AD. On the contrary,
      combined treatments, in persons at risk to develop AD, could represent the first line of
      intervention to delay the onset of cognitive impairment.

      SPECIFIC AIMS

        1. To investigate the combined effect of aerobic exercise, dietary habits, nutritional
           supplements, and cognitive training administered at three different levels of intensity
           on cognitive performance in subjective memory complaints individuals. The three
           different intensity levels of nonpharmacological treatments will be organized as
           follows: (i) No Treatment (NT) will include educational training (sham condition); (ii)
           Partial Treatment (PT) will include exclusively the consumption of a nutritional
           supplement and a training for a balanced diet; (iii) Full treatment (FT) will include
           all above condition plus computerized cognitive training (no sham condition) and aerobic
           fitness training.

        2. To investigate the effect of the above treatments (NT, PT, FT) on basic markers of
           magnetic resonance imaging (MRI) such as HV, WML and Brain Ventricle Volume (BVV) in
           subjective memory complaints individuals.

        3. To investigate the effect of NT, PT and FT on advanced MRI markers such as structural
           brain connectivity and brain resting networks in subjective memory complaints
           individuals.

      HYPHOTESIS AND SIGNIFICANCE An improvement in cognitive performances, basic (HV, WML, BVV)
      and advanced (structural brain connectivity and brain resting networks) MRI markers will be
      expected in FT group compared to NT group. Moreover, the investigators hypothesize an effect
      dependent of the number of combined treatments, thus the PT group is expected to show
      intermediate results (among NT and FT groups) in the cognitive performances, basic and
      advanced MRI markers previously described.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive functions</measure>
    <time_frame>12 months</time_frame>
    <description>Neuropsychological test performances</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Basic imaging marker 1</measure>
    <time_frame>12 months</time_frame>
    <description>Hippocampal volumes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic imaging marker 2</measure>
    <time_frame>12 months</time_frame>
    <description>White matter hyperintensities volumes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic imaging marker 3</measure>
    <time_frame>12 months</time_frame>
    <description>Brain ventricle volumes</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Advanced imaging marker 1</measure>
    <time_frame>12 months</time_frame>
    <description>Structural brain connectivity</description>
  </other_outcome>
  <other_outcome>
    <measure>Advanced imaging marker 2</measure>
    <time_frame>12 months</time_frame>
    <description>Functional networks connectivity at rest</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Lifestyle Risk Reduction</condition>
  <arm_group>
    <arm_group_label>No Treatment (NT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Educational training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partial Treatment (PT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutritional supplementation &amp; Counselling on a brain-healthy diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Full Treatment (FT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutritional supplementation &amp; Counselling on a brain-healthy diet &amp; Physical exercise training &amp; Computerized cognitive training</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional supplementation</intervention_name>
    <description>Daily consumption of Tramiprosate (100 mg) for 1 year</description>
    <arm_group_label>Partial Treatment (PT)</arm_group_label>
    <arm_group_label>Full Treatment (FT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Educational training</intervention_name>
    <description>16 educational lessons (twice a week): basic principles of different cognitive domains (e.g. memory, attention, perception) and educational DVD viewing.</description>
    <arm_group_label>No Treatment (NT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Counselling on a brain-healthy diet</intervention_name>
    <description>4 lessons on the principles of Mediterranean Diet lead by a nutritionist, aimed to teach how to include brain-healthy foods in daily diet (e.g. antioxidant, omega-3 fatty acids and vitamins). Each participant will receive the educational material presented.</description>
    <arm_group_label>Partial Treatment (PT)</arm_group_label>
    <arm_group_label>Full Treatment (FT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical exercise training</intervention_name>
    <description>80 sessions of physical exercise supervised by a Fitness Training Expert with the aim of achieving 150 minutes of moderate-intensity physical activity per week</description>
    <arm_group_label>Full Treatment (FT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Computerized cognitive training</intervention_name>
    <description>16 cognitive training sessions (twice a week) supervised by a psychologist, aimed to improve Attention, Processing speed, Memory, Social skills and Intelligence using BrainHQ (www.brainhq.com).</description>
    <arm_group_label>Full Treatment (FT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 60 and 80 years;

          -  presence of memory complaints

        Exclusion Criteria:

          -  objective cognitive impairment on standard neuropsychological testing;

          -  history of psychiatric disorders or current clinically relevant depressive or anxious
             symptoms;

          -  pacemakers, cochlear implant, metal inserts in the head or shoulders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrica Cavedo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Centro San Giovanni di Dio Fatebenefratelli</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Centro San Giovanni di Dio Fatebenefratelli</name>
      <address>
        <city>Brescia</city>
        <zip>25125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012 Jan 24;78(4):241-9. doi: 10.1212/WNL.0b013e3182436598. Epub 2011 Dec 28.</citation>
    <PMID>22205763</PMID>
  </reference>
  <reference>
    <citation>Cavedo E, Galluzzi S, Pievani M, Boccardi M, Frisoni GB. Norms for imaging markers of brain reserve. J Alzheimers Dis. 2012;31(3):623-33. doi: 10.3233/JAD-2012-111817.</citation>
    <PMID>22672878</PMID>
  </reference>
  <reference>
    <citation>Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22. doi: 10.1073/pnas.1015950108. Epub 2011 Jan 31.</citation>
    <PMID>21282661</PMID>
  </reference>
  <reference>
    <citation>Lampit A, Hallock H, Valenzuela M. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med. 2014 Nov 18;11(11):e1001756. doi: 10.1371/journal.pmed.1001756. eCollection 2014 Nov. Review.</citation>
    <PMID>25405755</PMID>
  </reference>
  <reference>
    <citation>Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.</citation>
    <PMID>21514248</PMID>
  </reference>
  <reference>
    <citation>Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Roberts RO, Lowe VJ, Kantarci K, Senjem ML, Gunter JL, Boeve BF, Petersen RC, Jack CR Jr. Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol. 2012 Nov;72(5):730-8. doi: 10.1002/ana.23665.</citation>
    <PMID>23280791</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2017</study_first_submitted>
  <study_first_submitted_qc>December 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2017</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Centro San Giovanni di Dio Fatebenefratelli</investigator_affiliation>
    <investigator_full_name>Enrica Cavedo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>primary prevention</keyword>
  <keyword>Subjective Cognitive Decline</keyword>
  <keyword>Neuroimaging</keyword>
  <keyword>Alzheimer's disease</keyword>
  <keyword>nonpharmacological interventions</keyword>
  <keyword>multidomain lifestyle interventions</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

